Sikiric et al., 2018), along with the evidence that pentadecapeptide BPC 157 may prevent and/or attenuate or eliminate, thus, counteract both developing and already formed both arterial thrombosis (Kolovrat et al., 2020), and venous thrombosis (Vukojevic et al., 2018
Mounjaro is the brand name for tirzepatide, a dual GIP and GLP-1 receptor agonist
The prolonged receptor activation, sustained IGF-1 elevation, and albumin-binding properties represent a different exposure profile that requires its own toxicology assessment
Effect of thiamine supplementation on glycaemic outcomes in adults with type 2 diabetes: a systematic review and meta-analysis
[11] [12] For patients without pre-existing hypertension, routine monitoring during diabetes reviews is generally sufficient
Serious Risks Both medications carry similar serious but rare risks: Pancreatitis: Can occur with either medication